<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35763279</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1827-675X</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>Suppl. 1</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale</Title><ISOAbbreviation>Acta Otorhinolaryngol Ital</ISOAbbreviation></Journal><ArticleTitle>Long COVID, audiovestibular symptoms and persistent chemosensory dysfunction: a systematic review of the current evidence.</ArticleTitle><Pagination><StartPage>S87</StartPage><EndPage>S93</EndPage><MedlinePgn>S87-S93</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.14639/0392-100X-suppl.1-42-2022-10</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">The persistence of auditory, vestibular, olfactory, and gustatory dysfunction for an extended time after COVID-19 has been documented, which represents an emerging challenge of which ENT specialists must be aware. This systematic review aims to evaluate the prevalence of persistent audiovestibolar and olfactory/gustatory symptoms in patients with "long-COVID".</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The literature was systematically reviewed according to PRISMA guidelines; PubMed, Scopus and Google Scholar were screened by searching articles on audiovestibular symptoms and olfactory/gustatory dysfunction after SARS-CoV-2 infection. The keywords used were hearing loss, tinnitus, vertigo, smell disorders, parosmia, anosmia, hyposmia, dysgeusia combined with COVID-19 or SARS-CoV-2.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">1100 articles were identified. After removal of duplicates (382), 702 articles were excluded, and 16 were included in the systematic review. All articles included identified an association between SARS-CoV-2 infection and persistent hearing or chemosensory impairment. The studies were published over a period of 2 years, between 2019 and 2021.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The likelihood of patients with persistent audiovestibular symptoms related to COVID-19 was different among the articles; however, olfactory and gustatory disturbances were more consistently reported. Studies with longer follow-up are required to fully evaluate the long-term impact of these conditions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Societ&#xe0; Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale, Rome, Italy.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>De Luca</LastName><ForeName>Pietro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Stadio</LastName><ForeName>Arianna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery and Biomedical Sciences, Section of Otorhinolaryngology, "Santa Maria della Misericordia" University Hospital, Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colacurcio</LastName><ForeName>Vito</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, University of Modena, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marra</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scarpa</LastName><ForeName>Alfonso</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ricciardiello</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Otolaryngology Department, AORN Cardarelli, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cassandro</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camaioni</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Otolaryngology Department, San Giovanni-Addolorata Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cassandro</LastName><ForeName>Ettore</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Acta Otorhinolaryngol Ital</MedlineTA><NlmUniqueID>8213019</NlmUniqueID><ISSNLinking>0392-100X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006311" MajorTopicYN="N">Hearing Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000857" MajorTopicYN="Y">Olfaction Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013651" MajorTopicYN="Y">Taste Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014717" MajorTopicYN="N">Vertigo</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="ita"><AbstractText Label="UNLABELLED">Sindrome &#x201c;Long COVID&#x201d;, sintomi otovestibolari e disturbi chemosensoriali persistenti: revisione sistematica delle attuali evidenze scientifiche.</AbstractText><AbstractText Label="OBIETTIVI" NlmCategory="UNASSIGNED">La persistenza di disfunzioni uditive, vestibolari, gustative e olfattive persistenti dopo la risoluzione del COVID-19 &#xe8; stata documentata in letteratura, e rappresenta una sfida emergente che necessita di una risposta adeguata da parte dello specialista otorinolaringoiatra. Lo scopo di questa revisione sistematica &#xe8; rivedere le attuali conoscenze sulla persistenza di questi sintomi.</AbstractText><AbstractText Label="METODI" NlmCategory="UNASSIGNED">&#xc8; stata effettuata una revisione sistematica della letteratura disponibile, in accordo con le linee guida PRISMA; PubMed, Scopus e Google Scholar sono stati sottoposti a screening cercando articoli sui sintomi audiovestibolari e sulla disfunzione olfattiva/gustativa dopo l&#x2019;infezione da SARS-CoV-2. Le parole chiave utilizzate sono state perdita dell&#x2019;udito, tinnito, vertigini, disturbi dell&#x2019;olfatto, parosmia, anosmia, iposmia, disgeusia sempre in combinazione con il termine COVID-19 o Sars-CoV-2. D.</AbstractText><AbstractText Label="RISULTATI" NlmCategory="UNASSIGNED">Sono stati identificati 1.110 articoli; dopo la rimozione dei duplicati (382), 702 articoli sono stati esclusi, e 16 articoli, che identificavano l&#x2019;associazione tra il SARS-CoV-2 e la persistenza di disturbi uditivi, vestibolari e chemosensoriali, e pubblicati tra il 2019 e il 2021, sono stati inclusi nella revisione sistematica.</AbstractText><AbstractText Label="CONCLUSIONI" NlmCategory="UNASSIGNED">La percentuale di pazienti che mostrano una persistenza di sintomi audiovestibolari dopo COVID-19 &#xe8; risultata variabile tra i diversi articoli, mentre le anomalie olfattive e gustative sono riportate pi&#xf9; costantemente. In futuro saranno necessari studi con follow-up pi&#xf9; lungo, in modo da valutare l&#x2019;impatto, a lungo termine, di questi disturbi.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Societ&#xe0; Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale, Rome, Italy.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">anosmia</Keyword><Keyword MajorTopicYN="N">post-acute COVID</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>28</Day><Hour>11</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35763279</ArticleId><ArticleId IdType="pmc">PMC9137376</ArticleId><ArticleId IdType="doi">10.14639/0392-100X-suppl.1-42-2022-10</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lv G, Yuan J, Xiong X, et al. . Mortality rate and characteristics of deaths following COVID-19 vaccination. Front Med (Lausanne) 2021;8:670370. https://doi.org/10.3389/fmed.2021.670370 10.3389/fmed.2021.670370</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.670370</ArticleId><ArticleId IdType="pmc">PMC8160119</ArticleId><ArticleId IdType="pubmed">34055843</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet. Facing up to long COVID. Lancet 2020;396:1861. https://doi.org/10.1016/S0140-6736(20)32662-3 10.1016/S0140-6736(20)32662-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32662-3</ArticleId><ArticleId IdType="pmc">PMC7834723</ArticleId><ArticleId IdType="pubmed">33308453</ArticleId></ArticleIdList></Reference><Reference><Citation>Bier-Laning C, Cramer JD, Roy S, et al. . Tracheostomy during the COVID-19 pandemic: comparison of international perioperative care protocols and practices in 26 countries. Otolaryngol Head Neck Surg 2021;164:1136-1147. https://doi.org/10.1177/0194599820961985 10.1177/0194599820961985</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599820961985</ArticleId><ArticleId IdType="pubmed">33138722</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ascanio L, Vitelli F, Cingolani C, et al. . Randomized clinical trial &#x201c;olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin&#x201d;: preliminary results. Eur Rev Med Pharmacol Sci 2021;25:4156-4162. https://doi.org/10.26355/eurrev_202106_26059 10.26355/eurrev_202106_26059</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202106_26059</ArticleId><ArticleId IdType="pubmed">34156697</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. . The PRISMA 2020 statement: an up-dated guideline for reporting systematic reviews. BMJ 2021;372:n71. https://doi.org/10.1136/bmj.n71 10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Viola P, Ralli M, Pisani D, et al. . Tinnitus and equilibrium disorders in COVID-19 patients: preliminary results. Eur Arch Otorhinolaryngol 2021;278:3725-3730. https://doi.org/10.1007/s00405-020-06440-7 10.1007/s00405-020-06440-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-06440-7</ArticleId><ArticleId IdType="pmc">PMC7582442</ArticleId><ArticleId IdType="pubmed">33095432</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatta S, Sharma S, Sharma D, et al. . Study of hearing status in COVID-19 patients: a multicentered review. Indian J Otolaryngol Head Neck Surg 2021. Jul 12;1-7. https://doi.org/10.1007/s12070-021-02710-w. 10.1007/s12070-021-02710-w Epub ahead of print.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12070-021-02710-w</ArticleId><ArticleId IdType="pmc">PMC8274964</ArticleId><ArticleId IdType="pubmed">34277385</ArticleId></ArticleIdList></Reference><Reference><Citation>Dror AA, Kassis-Karayanni N, Oved A, et al. . Auditory performance in recovered SARS-COV-2 patients. Otol Neurotol 2021;42:666-670. https://doi.org/10.1097/MAO.0000000000003037 10.1097/MAO.0000000000003037</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAO.0000000000003037</ArticleId><ArticleId IdType="pmc">PMC8115428</ArticleId><ArticleId IdType="pubmed">33967243</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallus R, Melis A, Rizzo D, et al. . Audiovestibular symptoms and sequelae in COVID-19 patients. J Vestib Res 2021;31:381-387. https://doi.org/10.3233/VES-201505 10.3233/VES-201505</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/VES-201505</ArticleId><ArticleId IdType="pubmed">33579886</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;ko&#x11f;lu K, Tekta&#x15f; N, Baktir-Okcesiz FEM, et al. . Mild and moderate COVID-19 disease does not affect hearing function permanently: a cross-sectional study &#x131;nvolving young and middle-aged healthcare givers. Eur Arch Otorhinolaryngol 2021;278:3299-3305. https://doi.org/10.1007/s00405-021-06883-6 10.1007/s00405-021-06883-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-021-06883-6</ArticleId><ArticleId IdType="pmc">PMC8238665</ArticleId><ArticleId IdType="pubmed">34185143</ArticleId></ArticleIdList></Reference><Reference><Citation>Thrane JF, Britze A, Fjaeldstad AW. Incidence and duration of self-reported hearing loss and tinnitus in a cohort of COVID-19 patients with sudden chemosensory loss: a STROBE observational study. Eur Ann Otorhinolaryngol Head Neck Dis 2021. Sep 30:S1879-7296(21)00224-6. https://doi.org/10.1016/j.anorl.2021.07.012. 10.1016/j.anorl.2021.07.012 Epub ahead of print.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anorl.2021.07.012</ArticleId><ArticleId IdType="pmc">PMC8482223</ArticleId><ArticleId IdType="pubmed">34602376</ArticleId></ArticleIdList></Reference><Reference><Citation>Gedik &#xd6;, H&#xfc;sam H, Ba&#x15f;&#xf6;z M, et al. . The effect of coronavirus disease 2019 on the hearing system. J Laryngol Otol 2021;135:810-814. https://doi.org/10.1017/S0022215121001961 10.1017/S0022215121001961</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022215121001961</ArticleId><ArticleId IdType="pubmed">34344488</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Chiesa-Estomba CM, Beckers E, et al. . Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients. J Intern Med 2021;290:451-461. https://doi.org/10.1111/joim.13209 10.1111/joim.13209</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13209</ArticleId><ArticleId IdType="pubmed">33403772</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, et al. . Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax 2021;76:405-407. https://doi.org/10.1136/thoraxjnl-2020-216377 10.1136/thoraxjnl-2020-216377</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216377</ArticleId><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Riestra-Ayora J, Yanes-Diaz J, Esteban-Sanchez J, et al. . Long-term follow-up of olfactory and gustatory dysfunction in COVID-19: 6 months case-control study of health workers. Eur Arch Otorhinolaryngol 2021;278:4831-4837. https://doi.org/10.1007/s00405-021-06764-y 10.1007/s00405-021-06764-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-021-06764-y</ArticleId><ArticleId IdType="pmc">PMC8004560</ArticleId><ArticleId IdType="pubmed">33774737</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussi&#xe8;re N, Mei J, L&#xe9;vesque-Boissonneault C, et al. . Chemosensory dysfunctions induced by COVID-19 can persist up to 7 months: a study of over 700 healthcare workers. Chem Senses 2021. Jan 1;46:bjab038. https://doi.org/10.1093/chemse/bjab038 10.1093/chemse/bjab038</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjab038</ArticleId><ArticleId IdType="pmc">PMC8499810</ArticleId><ArticleId IdType="pubmed">34423831</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrocelli M, Cutrupi S, Salzano G, et al. . Six-month smell and taste recovery rates in coronavirus disease 2019 patients: a prospective psychophysical study. J Laryngol Otol 2021;135:436-441. https://doi.org/10.1017/S002221512100116X 10.1017/S002221512100116X</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S002221512100116X</ArticleId><ArticleId IdType="pmc">PMC8111201</ArticleId><ArticleId IdType="pubmed">33888166</ArticleId></ArticleIdList></Reference><Reference><Citation>Biadsee A, Dagan O, Ormianer Z, et al. . Eight-month follow-up of olfactory and gustatory dysfunctions in recovered COVID-19 patients. Am J Otolaryngol 2021;42:103065. https://doi.org/10.1016/j.amjoto.2021.103065 10.1016/j.amjoto.2021.103065</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2021.103065</ArticleId><ArticleId IdType="pmc">PMC8055924</ArticleId><ArticleId IdType="pubmed">33894627</ArticleId></ArticleIdList></Reference><Reference><Citation>Zayet S, Zahra H, Royer PY, et al. . Post-COVID-19 syndrome: nine months after SARS-CoV-2 infection in a cohort of 354 patients: data from the first wave of COVID-19 in Nord Franche-Comt&#xe9; Hospital, France. Microorganisms 2021;9:1719. https://doi.org/10.3390/microorganisms9081719 10.3390/microorganisms9081719</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9081719</ArticleId><ArticleId IdType="pmc">PMC8401026</ArticleId><ArticleId IdType="pubmed">34442798</ArticleId></ArticleIdList></Reference><Reference><Citation>Otte MS, Bork ML, Zimmermann PH, et al. . Persisting olfactory dysfunction improves in patients 6 months after COVID-19 disease. Acta Otolaryngol 2021;14:626-629. https://doi.org/10.1080/00016489.2021.1905178 10.1080/00016489.2021.1905178</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00016489.2021.1905178</ArticleId><ArticleId IdType="pubmed">33823752</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Hummel T, Hopkins C, et al. . High prevalence of long-term olfactory, gustatory, and chemesthesis dysfunction in post-COVID-19 patients: a matched case-control study with one-year follow-up using a comprehensive psychophysical evaluation. Rhinology 2021;59:517-527. https://doi.org/10.4193/Rhin21.249 10.4193/Rhin21.249</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin21.249</ArticleId><ArticleId IdType="pubmed">34553706</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruol DL. IL-6 regulation of synaptic function in the CNS. Neuropharmacology 2015; 96(pt A):42&#x2013;54. https://doi.org/10.1016/j.neuropharm.2014.10.023 10.1016/j.neuropharm.2014.10.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2014.10.023</ArticleId><ArticleId IdType="pmc">PMC4446251</ArticleId><ArticleId IdType="pubmed">25445486</ArticleId></ArticleIdList></Reference><Reference><Citation>De Luca P, Scarpa A, Ralli M, et al. . Auditory disturbances and SARS-CoV-2 infection: brain inflammation or cochlear affection? Systematic review and discussion of potential pathogenesis. Front Neurol 2021;12:707207. https://doi.org/10.3389/fneur.2021.707207 10.3389/fneur.2021.707207</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.707207</ArticleId><ArticleId IdType="pmc">PMC8373381</ArticleId><ArticleId IdType="pubmed">34421805</ArticleId></ArticleIdList></Reference><Reference><Citation>Angileri F, Legare S, Marino Gammazza A, et al. . Molecular mimicry may explain multi-organ damage in COVID-19. Autoimmun Rev 2020;19:102591. https://doi.org/10.1016/j.autrev.2020.102591 10.1016/j.autrev.2020.102591</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102591</ArticleId><ArticleId IdType="pmc">PMC7289093</ArticleId><ArticleId IdType="pubmed">32535095</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandemirli SG, Altundag A, Yildirim D, et al. . Olfactory bulb MRI and paranasal sinus CT findings in persistent COVID-19 anosmia. Acad Radiol 2021;28:28-35. https://doi.org/10.1016/j.acra.2020.10.006 10.1016/j.acra.2020.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acra.2020.10.006</ArticleId><ArticleId IdType="pmc">PMC7571972</ArticleId><ArticleId IdType="pubmed">33132007</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibekwe TS, Fasunla AJ, Orimadegun AE. Systematic review and meta-analysis of smell and taste disorders in COVID-19. OTO Open 2020;4:2473974X20957975. https://doi.org/10.1177/2473974X20957975 10.1177/2473974X20957975</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2473974X20957975</ArticleId><ArticleId IdType="pmc">PMC7488903</ArticleId><ArticleId IdType="pubmed">32964177</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>